<?xml version="1.0" encoding="UTF-8"?>
<title-group>
 <article-title>Total neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy and adjuvant gemcitabine for resectable and borderline resectable pancreatic cancer (PREOPANC-2 trial): study protocol for a nationwide multicenter randomized controlled trial</article-title>
</title-group>
